Detected ·
Avenzo Therapeutics
——
Avenzo Therapeutics announced a merger agreement with Rallybio Corporation (Nasdaq: RLYB) and a concurrent oversubscribed $215M private placement financing to advance four clinical-stage oncology programs.
- Website
- www.avenzotx.com
- linkedin.com/company/avenzotx
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-01 20:13:15 UTC
- Signal ID
- c4cb049a-fcd7-4be2-a75f-fea729dc7432
As the API returns it
{
"id": "c4cb049a-fcd7-4be2-a75f-fea729dc7432",
"created_at": "2026-06-01T20:13:15.433566Z",
"company_name": "Avenzo Therapeutics",
"company_website_url": "www.avenzotx.com",
"company_linkedin_url": "https://www.linkedin.com/company/avenzotx",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Avenzo Therapeutics announced a merger agreement with Rallybio Corporation (Nasdaq: RLYB) and a concurrent oversubscribed $215M private placement financing to advance four clinical-stage oncology programs.*"
}